NCT00541411Unknown不适用
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma
适应症
相关药物
试验速览
- 阶段
- 不适用
- 入组人数
- 10
- 主要终点
- Efficacy
研究概览
简要总结
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide combination chemotherapy in Ewing's Sarcoma
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with Ewing's Sarcoma
排除标准
- 未提供
结局指标
主要结局
Efficacy
时间窗: overall
次要结局
未报告次要终点
研究者
Dr. Naeem A. Chaudhri
Principal Investigator
King Faisal Specialist Hospital & Research Center
相似试验
已完成
3 期
Combination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaAdult Malignant MesenchymomaAdult RhabdomyosarcomaAlveolar Childhood RhabdomyosarcomaChildhood Malignant MesenchymomaEmbryonal Childhood RhabdomyosarcomaEmbryonal-botryoid Childhood RhabdomyosarcomaNonmetastatic Childhood Soft Tissue SarcomaPreviously Untreated Childhood RhabdomyosarcomaStage I Adult Soft Tissue SarcomaStage II Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaNCT00003958Children's Oncology Group702
已完成
3 期
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaAdult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Botryoid-Type Embryonal RhabdomyosarcomaChildhood Embryonal RhabdomyosarcomaLocalized Childhood Soft Tissue SarcomaStage I Adult Soft Tissue Sarcoma AJCC v7Stage II Adult Soft Tissue Sarcoma AJCC v7Stage III Adult Soft Tissue Sarcoma AJCC v7SarcomaRhabdomyosarcomaNCT00354835Children's Oncology Group481
招募中
不适用
Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed intermediate rhabdomyosarcoma.rhabdomyosarcomaJPRN-UMIN000023956Japan Rhabdomyosarcoma Study Group40
招募中
2 期
Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma.rhabdomyosarcomaJPRN-UMIN000017004Japan Rhabdomyosarcoma Study Group18
招募中
2 期
Phase II study of VAC1.2/VI therapy for patients with newly diagnosed low-risk subset B rhabdomyosarcoma.rhabdomyosarcomaD012208JPRN-jRCTs051180200Miyachi Mitsuru18